UNI - EN REPORT No
UNI - EN REPORT No62/2019
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for October 2019 the Company recorded an increase in sales of 40% compared to the same month of 2018, incl. 30% increase in sales for the domestic market and 48% increase in export sales.
In the first ten months of 2019 the revenues from sales of production increased by 6% compared to the same period of 2018, incl. 4% decrease in domestic sales and 13% increase in export sales.